Long-term Effectiveness of a Recombinant Hepatitis E Vaccine

Status Recruiting

Clinical Trial Summary

This test-negative study is designed to evaluate the long-term effectiveness of hepatitis E vaccine (Hecolin®) and to explore the prevalence of rat hepatitis E in Dongtai City.

Clinical Trial Description

In this negative test study, residual clinical serum will be collected from 13 hospitals in Dongtai, if it was from patients born between 1941-1991 from 11 towns in Dongtai, who tested positive for ALT levels higher than 2.5 times the upper limit of normal (ULN). Detection of HEV IgM, IgG, antigen, RNA will be performed to diagnose hepatitis E (HE) in each individual. In addition, HE vaccination history will be collect. All the information above will be used to evaluate the long-term effectiveness of HE vaccine. Based on the study design, virological and serological detection (IgM, IgG, antigen, and RNA) of hepatitis E virus species C (HEV-C) will be performed to analyze the prevalence of rat hepatitis E infection in Dongtai. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05976594
Study type	Observational
Source	Xiamen University
Contact	Zhang Jun, PhD
Phone	0592-2184110
Email	zhangj@xmu.edu.cn
Status	Recruiting
Phase
Start date	August 12, 2023
Completion date	July 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03365921` - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)	Phase 4
Completed	`NCT02584543` - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)	Phase 4
Not yet recruiting	`NCT03488589` - HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver
Completed	`NCT03601221` - Seroprevalence Hepatitis E Infection in Healthy Blood Donors
Completed	`NCT03168412` - A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)	Phase 4
Completed	`NCT02189603` - Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）	Phase 4
Completed	`NCT02847507` - Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)
Completed	`NCT02603055` - A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults	Phase 1
Completed	`NCT02190253` - Seroprevalence of Hepatitis E in People With an Organ Transplant
Recruiting	`NCT06457438` - Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors	N/A
Completed	`NCT04670419` - Morbidity and Mortality of Hepatitis E Virus Infections in Belgium
Completed	`NCT03282474` - HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)	Phase 2
Terminated	`NCT02558114` - Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.	Phase 4
Recruiting	`NCT06137313` - Exposure to Hepatitis E Virus in Occitania, France
Completed	`NCT02964910` - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )	Phase 4
Completed	`NCT01014845` - Clinical Trial of Recombinant Hepatitis E Vaccine	Phase 3
Completed	`NCT02417597` - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)	Phase 4
Completed	`NCT03827395` - Safety Study of Hepatitis E Vaccine (HEV239)	Phase 1